Skip to main content
Caplight Logo









Clairity, Inc.

Clairity, Inc.

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://clairity.com/

Last Round

Series B

Nov 13, 2025

Total Funding Raised

$50.67M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Clairity, Inc. is a healthcare AI company that provides an AI platform for breast cancer risk prediction.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

medical imagingbreast cancer screeningsoftware as a medical deviceSaMDAI diagnosticsradiology AIrisk predictionclinical decision supportFDA authorized AImammography AIcomputer visionclinical workflow integrationusage-based SaaSmedtechhealthtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Clairity, Inc. Comparables

Compare Clairity, Inc. with similar companies based on industry and business-model similarity.

Clairity, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ataraxis AI
84%
ScreenPoint Medical
83%
MICA AI Medical
83%

Clairity, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 13, 2025
GrantJan 13, 2025
Series AOct 17, 2022

Clairity, Inc. Investors

Notable investors and investment history

Clairity, Inc. investors
InvestorRounds
Breast Cancer Research FoundationSeries A, Series B, Grant
Santé VenturesSeries A, Series B
Santé VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 3, 2026

    Grew 27% QoQ, from 15 to 19 employees.

  • Sep 3, 2026

    Grew 20% QoQ, from 15 to 18 employees.

Recent news

Latest coverage and updates

  • partners_withOct 2, 2026

    Clairity, Inc. partnered with Everlywell, Inc. to expand access to the technology nationwide in the United States on Oct 1st '26

Clairity, Inc. Filings

Explore SEC and related filing metadata, where available.

Clairity, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Clairity, Inc.'s valuation, stock price, and market status.

Is Clairity, Inc. a public or private company?

Clairity, Inc. is a private company.

What is the current stock price of Clairity, Inc.?

Clairity, Inc. is a private company, so its shares have no public market price. Caplight tracks Clairity, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Clairity, Inc. worth (valuation)?

Valuation information for Clairity, Inc. is not publicly available.

Can I buy Clairity, Inc. stock?

Clairity, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Clairity, Inc.'s last funding round?

Clairity, Inc.'s most recent funding round was Series B on November 13, 2025.

Who are the main investors in Clairity, Inc.?

Key investors in Clairity, Inc. include Breast Cancer Research Foundation, Santé Ventures, Santé Ventures.

Will Clairity, Inc. IPO soon?

No public IPO plans have been announced for Clairity, Inc..

How can I track Clairity, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Clairity, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range16
Year Founded2020
Last FundingNov 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?